Point72 Asset Management, L.P.
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1603466
STAMFORD, CT
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,314,672
-$1,598,677 QoQ
Shares Held
322,836
+27.0% QoQ
Ownership
0.313%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. VRDN ranks #75 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in VRDN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,314,672 | 322,836 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,913,349 | 254,285 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $1,454,521 | 104,043 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,759,382 | 204,702 | Shares | Defined | 2025-07-21 | |
| 2024-09-30 | $787,764 | 34,627 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $6,737,189 | 439,191 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $1,452,624 | 57,100 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,597,258 | 260,091 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $5,880,360 | 286,707 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,144,928 | 790,400 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,547,000 | 300,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,348,521 | 472,864 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,034,500 | 610,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,234,316 | 395,534 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,609,373 | 395,534 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||